[604] | 1 | English French Notes Complete/Exclude
|
---|
| 2 | Venous Invasion (V):
|
---|
| 3 | Other Stage:
|
---|
| 4 | Physician Staging:
|
---|
| 5 | Tumor Size:
|
---|
| 6 | Pathologic Extension:
|
---|
| 7 | Lymph Nodes:
|
---|
| 8 | Metastasis 1:
|
---|
| 9 | Regional Nodes Examined:
|
---|
| 10 | Metastasis 2:
|
---|
| 11 | Regional Nodes Positive:
|
---|
| 12 | Metastasis 3:
|
---|
| 13 | General Summary Stage:
|
---|
| 14 | Peripheral Blood Involvement:
|
---|
| 15 | Associated With HIV:
|
---|
| 16 | Surgical Dx/Staging Proc:
|
---|
| 17 | Surgical Dx/Staging Proc Date:
|
---|
| 18 | Surg Dx/Staging Proc @Fac:
|
---|
| 19 | Surg Dx/Staging Proc @Fac Date:
|
---|
| 20 | Date of no treatment:
|
---|
| 21 | Surgery of Primary (R):
|
---|
| 22 | Surgery of Primary (F):
|
---|
| 23 | Surgery of Primary Date:
|
---|
| 24 | Surgery of Primary @Fac (R):
|
---|
| 25 | Surgery of Primary @Fac (F):
|
---|
| 26 | Surgery of Primary @Fac Date:
|
---|
| 27 | Surgical Approach (R):
|
---|
| 28 | Surgical Margins:
|
---|
| 29 | Scope of LN Surgery (R):
|
---|
| 30 | Scope of LN Surgery (F):
|
---|
| 31 | Scope of LN Surgery Date:
|
---|
| 32 | Scope of LN Surgery @Fac (R):
|
---|
| 33 | Scope of LN Surgery @Fac (F):
|
---|
| 34 | Scope of LN Surgery @Fac Date:
|
---|
| 35 | Surg Proc/Other Site (R):
|
---|
| 36 | Surg Proc/Other Site (F):
|
---|
| 37 | Surg Proc/Other Site Date:
|
---|
| 38 | Surg Proc/Other Site @Fac (R):
|
---|
| 39 | Surg Proc/Other Site @Fac (F):
|
---|
| 40 | Surg Proc/Other Site @Fac Date:
|
---|
| 41 | Date of Surgical Discharge:
|
---|
| 42 | Reason for No Surgery:
|
---|
| 43 | RX Text-Surgery:
|
---|
| 44 | Date Radiation Started:
|
---|
| 45 | Location of Radiation Tx:
|
---|
| 46 | Radiation Treatment Volume:
|
---|
| 47 | Regional Treatment Modality:
|
---|
| 48 | Regional Dose: cGy:
|
---|
| 49 | Boost Treatment Modality:
|
---|
| 50 | Boost Dose: cGy:
|
---|
| 51 | Number of Txs to this Volume:
|
---|
| 52 | Date Radiation Ended:
|
---|
| 53 | Radiation @Fac Date:
|
---|
| 54 | Radiation/Surgery Sequence:
|
---|
| 55 | Reason for No Radiation:
|
---|
| 56 | RX Text-Radiation (Beam):
|
---|
| 57 | RX Text-Radiation Other:
|
---|
| 58 | Chemotherapy Date:
|
---|
| 59 | Chemotherapy @Fac Date:
|
---|
| 60 | RX Text-Chemo:
|
---|
| 61 | Hormone Therapy:
|
---|
| 62 | Hormone Therapy Date:
|
---|
| 63 | Hormone Therapy @Fac:
|
---|
| 64 | Hormone Therapy @Fac Date:
|
---|
| 65 | RX Text-Hormone:
|
---|
| 66 | Immunotherapy Date:
|
---|
| 67 | Immunotherapy @Fac Date:
|
---|
| 68 | RX Text-BRM:
|
---|
| 69 | Hema Trans/Endocrine Proc:
|
---|
| 70 | Hema Trans/Endocrine Proc Date:
|
---|
| 71 | Other Treatment:
|
---|
| 72 | Other Treatment Date:
|
---|
| 73 | Other Treatment @Fac:
|
---|
| 74 | Other Treatment @Fac Date:
|
---|
| 75 | RX Text-Other:
|
---|
| 76 | Pain Assessment:
|
---|
| 77 | Palliative Procedure:
|
---|
| 78 | Palliative Procedure @Fac:
|
---|
| 79 | Protocol Participation:
|
---|
| 80 | Year Put on Protocol:
|
---|
| 81 | Text Dx Proc-Phys.Exam:
|
---|
| 82 | Text Dx Proc-Xray/Scan:
|
---|
| 83 | Text Dx Proc-Operations:
|
---|
| 84 | Text Dx Proc-Lab Tests:
|
---|
| 85 | Text Dx Proc-Endoscopy:
|
---|
| 86 | Text Dx Proc-Path/Cyto:
|
---|
| 87 | Date of First Recurrence:
|
---|
| 88 | Type of First Recurrence:
|
---|
| 89 | Distant Site 1:
|
---|
| 90 | Distant Site 2:
|
---|
| 91 | Distant Site 3:
|
---|
| 92 | Subsequent Recurrence Date:
|
---|
| 93 | Type of Subsequent Recurrence:
|
---|
| 94 | SUBSEQUENT COURSE OF THERAPY
|
---|
| 95 | Date Started:
|
---|
| 96 | Surgery of Primary Site:
|
---|
| 97 | Scope of Lymph Node Surg:
|
---|
| 98 | Number of Nodes Removed:
|
---|
| 99 | Surgery of Other Sites/Nodes:
|
---|
| 100 | Radiation Sequence:
|
---|
| 101 | Radiation Therapy to CNS:
|
---|
| 102 | OTHER PRIMARY SITES
|
---|
| 103 | Abst Status
|
---|
| 104 | No Other Primary Sites
|
---|
| 105 | PERSONAL DATA
|
---|
| 106 | Address at Dx:
|
---|
| 107 | Address at Dx - Supp:
|
---|
| 108 | City/Town at Dx:
|
---|
| 109 | Place of Birth:
|
---|
| 110 | State at Dx:
|
---|
| 111 | Postal Code at Dx:
|
---|
| 112 | Marital Status at Dx:
|
---|
| 113 | County at Dx:
|
---|
| 114 | Primary Payer at Dx:
|
---|
| 115 | Next of Kin:
|
---|
| 116 | Abstract Status :
|
---|
| 117 | Abstract Date:
|
---|
| 118 | Abstracted by:
|
---|
| 119 | Agent Orange Exposure:
|
---|
| 120 | Ionizing Radiation Exposure:
|
---|
| 121 | Chemical Exposure:
|
---|
| 122 | Asbestos Exposure:
|
---|
| 123 | Persian Gulf Service:
|
---|
| 124 | Middle East Service:
|
---|
| 125 | Somalia Service:
|
---|
| 126 | Comorbidity/Complication #1:
|
---|
| 127 | Comorbidity/Complication #2:
|
---|
| 128 | Comorbidity/Complication #3:
|
---|
| 129 | Comorbidity/Complication #4:
|
---|
| 130 | Comorbidity/Complication #5:
|
---|
| 131 | Comorbidity/Complication #6:
|
---|
| 132 | EMPLOYMENT HISTORY
|
---|
| 133 | Usual Industry:
|
---|
| 134 | TOBACCO AND ALCOHOL USAGE
|
---|
| 135 | TOBACCO HISTORY:
|
---|
| 136 | Type of Tobacco User:
|
---|
| 137 | CHEWING TOBACCO
|
---|
| 138 | MORE THAN 1 TYPE
|
---|
| 139 | Pack-Years:
|
---|
| 140 | Year Quit Tobacco Use:
|
---|
| 141 | ALCOHOL HISTORY:
|
---|
| 142 | Type of Alcohol User:
|
---|
| 143 | HARD LIQUOR
|
---|
| 144 | MODERATE/SOCIAL
|
---|
| 145 | SERIOUS/HEAVY
|
---|
| 146 | Years of Alcohol Use:
|
---|
| 147 | Drinks Per Day:
|
---|
| 148 | Year Quit Drinking:
|
---|
| 149 | CANCER FAMILY HISTORY:
|
---|
| 150 | Family member with cancer:
|
---|
| 151 | PHYSICIAN CONTACTS
|
---|
| 152 | Following Physician:
|
---|
| 153 | Primary Surgeon:
|
---|
| 154 | QA Selected:
|
---|
| 155 | QA Reviewer:
|
---|
| 156 | QA Date:
|
---|
| 157 | QA Review:
|
---|
| 158 | QA Findings:
|
---|
| 159 | FOLLOW-UP HISTORY
|
---|
| 160 | Date of Last Contact:
|
---|
| 161 | Last Tumor Status:
|
---|
| 162 | Date of Death:
|
---|
| 163 | Cause of Death:
|
---|
| 164 | ICD Cause of Death:
|
---|
| 165 | State Death Cert:
|
---|
| 166 | ICD Revision:
|
---|
| 167 | Place of Death:
|
---|
| 168 | Care Center at Death:
|
---|
| 169 | Autopsy Date/Time:
|
---|
| 170 | Autopsy No.:
|
---|
| 171 | TUMOR Status at DEATH (Multiple Primaries)
|
---|
| 172 | Last Contact:
|
---|
| 173 | Follow-up Method:
|
---|
| 174 | Readmission (inpatient or outpatient)
|
---|
| 175 | Vital Status:
|
---|
| 176 | Next Follow-up Method:
|
---|
| 177 | Quality of Survival:
|
---|
| 178 | Unusual Follow-up Method:
|
---|
| 179 | 1st unusual method
|
---|
| 180 | 2nd unusual method
|
---|
| 181 | Date Entered:
|
---|
| 182 | Registrar:
|
---|
| 183 | Following Registry:
|
---|
| 184 | Select year
|
---|
| 185 | @#ACCESSION YEAR,ACC/SEQ NUMBER
|
---|
| 186 | ANNUAL Patient Index - ACOS Required (132col)
|
---|
| 187 | #@ACCESSION YEAR,@PATIENT NAME
|
---|
| 188 | ANNUAL Patient List by Class of Case (80c)
|
---|
| 189 | @ACCESSION YEAR,+#@CLASS CATEGORY,+CLASS OF CASE,@PATIENT NAME
|
---|
| 190 | ANNUAL Site/Gp Listing by ICDO-Topography/Histology
|
---|
| 191 | @ACCESSION YEAR,+@CLASS CATEGORY,#SITE/GP;S1;C20,+ICDO-TOPOGRAPHY;C12,+HISTOLOGY (ICD-O-2);C9
|
---|
| 192 | ANNUAL Site/GP Index by ICDO-Topography (132)
|
---|
| 193 | @ACCESSION YEAR,@CLASS CATEGORY,#@SITE/GP
|
---|
| 194 | Annual report - sorted first by Accession year
|
---|
| 195 | Then by Class Category (Non-analytic/Analytic)
|
---|
| 196 | Then by Status, Site/GP, and Diagnosis Age Gp.
|
---|
| 197 | Enter four digit ACCESSION YEAR,
|
---|
| 198 | for Class category: either 'A'
|
---|
| 199 | for Analytic, or first to last.
|
---|
| 200 | YOU may customize your own reports using this option
|
---|
| 201 | See the FileManager Manual for detailed instructions
|
---|
| 202 | CREATE CUSTOM REPORT for
|
---|
| 203 | There is no ICDO-TOPOGRAPHY for this primary.
|
---|
| 204 | There is currently no PCE for this primary site
|
---|
| 205 | nor is it a 1997 Non-Hodgkin's Lymphoma or 1999
|
---|
| 206 | Melanoma.
|
---|
| 207 | '00/00/00' is ambiguous, enter a 4 digit year.
|
---|
| 208 | '88/88/88' is ambiguous, enter a 4 digit year.
|
---|
| 209 | '99/99/99' is ambiguous, enter a 4 digit year.
|
---|
| 210 | LOOKING FOR Address at Diagnosis - Get from MAS
|
---|
| 211 | DONE CONVERTING ADDRESS AT DX
|
---|
| 212 | Select Type Abstract
|
---|
| 213 | Select Option
|
---|
| 214 | Select Patient to Print:
|
---|
| 215 | ALL PATIENT ABSTRACTS
|
---|
| 216 | Select Site/GP to Print:
|
---|
| 217 | ONCOLOGY MULTIPLE SITE ABSTRACTS
|
---|
| 218 | Select Site/GP:
|
---|
| 219 | SITE GPS for 19
|
---|
| 220 | Timed out...
|
---|
| 221 | ALL ABSTRACTS for 19
|
---|
| 222 | Select Beginning Date:
|
---|
| 223 | Choose Ending Date:
|
---|
| 224 | ONCOD*
|
---|
| 225 | ABSTRACTS BY DXDT
|
---|
| 226 | Define an AUTHORIZED QA USER in the ONCOLOGY SITE PARAMETERS file
|
---|
| 227 | Not an AUTHORIZED QA USER
|
---|
| 228 | Time frame: ABSTRACT DATE (Completed)
|
---|
| 229 | Select Beginning Date
|
---|
| 230 | Choose Ending Date
|
---|
| 231 | 10% QA REPORT-1
|
---|
| 232 | 10% QA REPORT-2
|
---|
| 233 | CANNOT DELETE THIS ENTRY
|
---|
| 234 | ONCO ABSTRACT NOT-COMPLETE
|
---|
| 235 | ONCO ACCREG-ACOS80
|
---|
| 236 | ONCO ACCREG-EOVA132
|
---|
| 237 | ONCO ACCREG-SITE/GP80
|
---|
| 238 | ONCO ACOS DOCUMENTATION
|
---|
| 239 | ONCO AJCC SUMMARY STAGE GPS
|
---|
| 240 | ONCO ANNUAL ACCREG80
|
---|
| 241 | ONCO ANNUAL ACCREG80-HDR
|
---|
| 242 | ONCO ANNUAL CLASS/PATIENT
|
---|
| 243 | ONCO ANNUAL CLASS/PATIENT-HDR
|
---|
| 244 | ONCO ANNUAL HIST/SITE/ICDO
|
---|
| 245 | ONCO ANNUAL ICDO/STAGE/TX
|
---|
| 246 | ONCO ANNUAL PATIENT INDX
|
---|
| 247 | ONCO ANNUAL PATIENT INDX-HDR
|
---|
| 248 | ONCO ANNUAL PATIENT INFO
|
---|
| 249 | ONCO ANNUAL PATIENT INFO-HDR
|
---|
| 250 | ONCO ANNUAL SITE/GP
|
---|
| 251 | ONCO ANNUAL SITE/GP-HDR
|
---|
| 252 | ONCO ANNUAL SITE/ICDT/ICDM
|
---|
| 253 | ONCO ANNUAL SITE/STAGE/TX
|
---|
| 254 | ONCO ANNUAL SITE/STAGE/TX-HDR
|
---|
| 255 | ONCO ANNUAL SITE/STG/TX
|
---|
| 256 | ONCO ANNUAL TREATMENT
|
---|
| 257 | ONCO CASEFINDING-HDR
|
---|
| 258 | ONCO CONTACT LIST-A
|
---|
| 259 | ONCO CONTACT LIST-T
|
---|
| 260 | ONCO DELINQUENT(LTF) LIST
|
---|
| 261 | ONCO DUE FOLLOWUP
|
---|
| 262 | ONCO DUE FOLLOWUP-ADM/DIS
|
---|
| 263 | ONCO DUE FOLLOWUP-ADM/DIS-HDR
|
---|
| 264 | ONCO DUE FOLLOWUP-HDR
|
---|
| 265 | ONCO DUE FOLLOWUP/TERMDIG
|
---|
| 266 | ONCO DUE FOLLOWUP/TERMDIG-HDR
|
---|
| 267 | ONCO F/U HISTORY (NEW)
|
---|
| 268 | ONCO FOLLOW-UP STATUS LIST
|
---|
| 269 | ONCO FOLLOWUP HISTORY
|
---|
| 270 | ONCO FOLLOWUP HISTORY-HDR
|
---|
| 271 | ONCO FOLLOWUP PATIENT RPT
|
---|
| 272 | ONCO FOLLOWUP PATIENT RPT-HDR
|
---|
| 273 | ONCO FOLLOWUP STATUS RPT
|
---|
| 274 | ONCO ICDO PATIENT LIST
|
---|
| 275 | ONCO ICDO-SITE132
|
---|
| 276 | ONCO ICDO-SITE132-HDR
|
---|
| 277 | ONCO ICDO-SITE80
|
---|
| 278 | ONCO ICDO-SITE80-HDR
|
---|
| 279 | ONCO LAB-CASEFINDING REPORT
|
---|
| 280 | ONCO LAB-CASEFINDING-HDR
|
---|
| 281 | ONCO NEG-REPORT
|
---|
| 282 | ONCO PATIENT INDX-ACOS
|
---|
| 283 | ONCO PATIENT INDX-ACOS-HDR
|
---|
| 284 | ONCO PATIENT INDX-EOVA132
|
---|
| 285 | ONCO PATIENT INDX80
|
---|
| 286 | ONCO PATIENT ONLY
|
---|
| 287 | ONCO PATIENT ONLY-HDR
|
---|
| 288 | ONCO PRIMARY EXTENT CODE AUDIT
|
---|
| 289 | ONCO PRIMARY INFORMATION132
|
---|
| 290 | ONCO PRIMARY SURGERY AUDIT
|
---|
| 291 | ONCO PTF-CASEFINDING RPT
|
---|
| 292 | ONCO PTF-CASEFINDING-HDR
|
---|
| 293 | ONCO RAD-CASEFINDING RPT
|
---|
| 294 | ONCO RAD-CASEFINDING-HDR
|
---|
| 295 | ONCO SITE HEADING
|
---|
| 296 | ONCO SITE-QA REPORT
|
---|
| 297 | ONCO SITE/GP80
|
---|
| 298 | ONCO SITE/GP80-HDR
|
---|
| 299 | ONCO SITE80
|
---|
| 300 | ONCO SITE80-HEADER
|
---|
| 301 | ONCO SUSPENSE
|
---|
| 302 | ONCO SUSPENSE-ALL/TERMDIG
|
---|
| 303 | #################### #################### ####################
|
---|
| 304 | #################### #################### ####################
|
---|
| 305 | #################### #################### ####################
|
---|
| 306 | #################### #################### ####################
|
---|
| 307 | #################### #################### ####################
|
---|